Drug firm Divi’s Laboratories’ consolidated net profit rose by 23.81% to Rs 216.91 crore for the fourth quarter ended December 31, 2012, on account of robust sales during the quarter. The company had posted a net profit of Rs 175.19 crore during the same period of previous fiscal.
The company’s net sales rose by 47.50% to Rs 722.53 crore for the fourth quarter, as compared to Rs 489.82 crore during the same period previous financial year.
For the year ended March 31, 2012, the company reported a jump of 24.23% in its net profit of Rs 533.26 crore as against Rs 429.27 crore during 2010-11.
The company’s net sales for the year ended March 31, 2012 rose to Rs 1920.01 crore, compared to Rs 1343.66 crore during 2010-11, up by 42.89%.
The company’s board recommended a dividend of Rs 13 per share of Rs 2 each for the year ended March 31, 2012.
